Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Classification of Neurotransmitters01:30

Classification of Neurotransmitters

Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
Neurotransmitters01:30

Neurotransmitters

Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet mitochondrial transfer via extracellular vesicles modulates neutrophil phenotype and function.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Platelets and inflammation-insights from platelet non-coding RNA content and release in the Bruneck study and the PACMAN-AMI trial.

Cardiovascular research·2025
Same author

Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning.

Research and practice in thrombosis and haemostasis·2024
Same author

Factors that modulate platelet reactivity as measured by 5 assay platforms in 3429 individuals.

Research and practice in thrombosis and haemostasis·2024
Same author

Oral nitrate supplementation improves cardiovascular risk markers in COPD: ON-BC, a randomised controlled trial.

The European respiratory journal·2023
Same author

Immature platelet dynamics are associated with clinical outcomes after major trauma.

Journal of thrombosis and haemostasis : JTH·2023
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
Same journal

A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles.

Pharmacology & therapeutics·2026
Same journal

GPCR crosstalk beyond obligate dimerisation: Effector coincidence detection, compartmentation, and pharmacological implications.

Pharmacology & therapeutics·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Gasotransmitters and platelets.

Nicola J Truss1, Timothy D Warner

  • 1The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK. n.j.truss@qmul.ac.uk

Pharmacology & Therapeutics
|July 19, 2011
PubMed
Summary
This summary is machine-generated.

Gasotransmitters like nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S) regulate platelet activity. These gaseous molecules, particularly NO and CO, inhibit platelet function, with H2S also showing inhibitory potential.

More Related Videos

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Related Experiment Videos

Last Updated: May 31, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation
07:13

Platelet-based Detection of Nitric Oxide in Blood by Measuring VASP Phosphorylation

Published on: January 7, 2019

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

Area of Science:

  • Biochemistry
  • Physiology
  • Pharmacology

Background:

  • Platelets are crucial for hemostasis and wound healing.
  • Platelet activation is a complex process regulated by various mediators.
  • Gasotransmitters, including nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S), are emerging as key regulators.

Purpose of the Study:

  • To review the role of gasotransmitters in modulating platelet activity.
  • To discuss the mechanisms of action of NO, CO, and H2S on platelets.
  • To explore the potential therapeutic applications of gasotransmitters in platelet-related conditions.

Main Methods:

  • Literature review of existing studies on gasotransmitters and platelet function.
  • Analysis of biochemical pathways involved in gasotransmitter signaling in platelets.
  • Examination of in vivo and in vitro evidence for gasotransmitter effects on platelets.

Main Results:

  • Nitric oxide (NO) is a potent platelet inhibitor via soluble guanylyl cyclase activation and decreased intracellular calcium.
  • Carbon monoxide (CO) also inhibits platelets through a similar mechanism but is less potent than NO.
  • Hydrogen sulfide (H2S) appears to have generally inhibitory effects on platelet function, though its mechanisms are still under investigation.

Conclusions:

  • Gasotransmitters play significant roles in regulating platelet activity.
  • Combined actions and interactions between gasotransmitters likely represent more physiologically relevant platelet regulation.
  • Gasotransmitters hold promise as therapeutic agents for conditions involving platelet dysfunction.